Iguana Healthcare Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Iguana Healthcare Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,000	Closed	-$809K	–	85
2016 Q4	$809K	Buy	+50,000	New	+$907K	0.48%	47
2016 Q1	–	Sell	-75,000	Closed	-$1.63M	–	95
2015 Q4	$1.63M	Sell	75,000 -125,000	-63%	-$2.43M	0.53%	52
2015 Q3	$3.96M	Hold	200,000	–	–	1.56%	21
2015 Q2	$6.95M	Hold	200,000	–	–	2.19%	15
2015 Q1	$5.19M	Hold	200,000	–	–	2.18%	16
2014 Q4	$2.58M	Sell	200,000 -20,000	-9%	-$250K	1.25%	33
2014 Q3	$2.7M	Sell	220,000 -35,000	-14%	-$407K	1.44%	25
2014 Q2	$4.04M	Sell	255,000 -65,000	-20%	-$928K	1.88%	19
2014 Q1	$4.84M	Buy	+320,000	New	+$3.61M	2.24%	10

Other funds holding HZNP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Iguana Healthcare Management's HZNP Position: Q1 2017 in Review

Iguana Healthcare Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2017, closing a stake of 50,000 shares — an estimated $809K sold.

Iguana Healthcare Management first reported a position in HZNP in Q1 2014 and held it in 9 quarters. The position peaked at $6.95M in Q2 2015. 210 funds tracked by Wall St. Rank hold HZNP as of Q1 2017.

Iguana Healthcare Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2017 after selling out during the quarter.
Iguana Healthcare Management sold 50,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2017, an estimated $809K.
Iguana Healthcare Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 9 quarters.
Iguana Healthcare Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.95M in Q2 2015.
210 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.